Hepatocyte growth factor (HGF) could induce acquired resistance to TKIs by restoring the PI3K/Akt signaling pathway via phosphorylation of MET in EGFR mutant NSCLC (109). Here, AKT1 is linked to non-small cell lung carcinoma.